Christopher Cabell, EVP, Head of R&D, and CMO at ARENA PHARMACEUTICALS INC (ARNA), sold 13,000 shares at $68.00 ($884K) on 2020-07-15, disclosed to the SEC on 2020-07-17.
Open-market sale of $884k ARNA by EVP, Head of R&D, and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.